Geoffrey Porges
Stock Analyst at SVB Leerink
(0.86)
# 2,783
Out of 4,479 analysts
113
Total ratings
41.86%
Success rate
-7.73%
Average return
Main Sectors:
Top Industries:
20 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PFE Pfizer | Maintains: Market Perform | n/a | $27.83 | - | 10 | Dec 15, 2021 | |
| RDUS Radius Health | Maintains: Market Perform | n/a | $14.67 | - | 9 | Dec 9, 2021 | |
| RCUS Arcus Biosciences | Maintains: Outperform | n/a | $14.65 | - | 6 | Nov 18, 2021 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | n/a | $1,044.66 | - | 11 | Nov 5, 2021 | |
| HALO Halozyme Therapeutics | Maintains: Outperform | n/a | $51.30 | - | 2 | Nov 3, 2021 | |
| AMGN Amgen | Maintains: Market Perform | n/a | $310.77 | - | 10 | Nov 3, 2021 | |
| ABBV AbbVie | Maintains: Outperform | n/a | $165.96 | - | 12 | Nov 1, 2021 | |
| ROIV Roivant Sciences | Initiates: Outperform | n/a | $10.56 | - | 1 | Nov 1, 2021 | |
| GILD Gilead Sciences | Maintains: Outperform | n/a | $68.40 | - | 11 | Oct 29, 2021 | |
| SNY Sanofi | Upgrades: Outperform | n/a | $48.54 | - | 2 | Sep 27, 2021 | |
| TBPH Theravance Biopharma | Maintains: Outperform | n/a | $8.32 | - | 9 | Sep 16, 2021 | |
| FGEN FibroGen | Maintains: Outperform | n/a | $0.74 | - | 5 | Aug 10, 2021 | |
| TBIO Telesis Bio | Maintains: Market Perform | $342 → $684 | $3.74 | +18,189.26% | 7 | Aug 3, 2021 | |
| VRTX Vertex Pharmaceuticals | Maintains: Underperform | n/a | $473.78 | - | 8 | Jul 30, 2021 | |
| MOR MorphoSys AG | Upgrades: Outperform | n/a | $18.10 | - | 2 | Jun 3, 2021 | |
| ASMB Assembly Biosciences | Maintains: Market Perform | $96 → $84 | $13.35 | +529.21% | 3 | May 10, 2021 | |
| GSK GSK | Downgrades: Market Perform | n/a | $38.21 | - | 1 | Mar 23, 2021 | |
| OPT Opthea | Initiates: Outperform | n/a | $1.93 | - | 1 | Nov 11, 2020 | |
| WVE Wave Life Sciences | Initiates: Outperform | n/a | $5.22 | - | 2 | Nov 28, 2018 | |
| BIIB Biogen | Downgrades: Market Perform | n/a | $228.82 | - | 1 | Mar 16, 2017 |
Pfizer
Dec 15, 2021
Maintains: Market Perform
Price Target: n/a
Current: $27.83
Upside: -
Radius Health
Dec 9, 2021
Maintains: Market Perform
Price Target: n/a
Current: $14.67
Upside: -
Arcus Biosciences
Nov 18, 2021
Maintains: Outperform
Price Target: n/a
Current: $14.65
Upside: -
Regeneron Pharmaceuticals
Nov 5, 2021
Maintains: Outperform
Price Target: n/a
Current: $1,044.66
Upside: -
Halozyme Therapeutics
Nov 3, 2021
Maintains: Outperform
Price Target: n/a
Current: $51.30
Upside: -
Amgen
Nov 3, 2021
Maintains: Market Perform
Price Target: n/a
Current: $310.77
Upside: -
AbbVie
Nov 1, 2021
Maintains: Outperform
Price Target: n/a
Current: $165.96
Upside: -
Roivant Sciences
Nov 1, 2021
Initiates: Outperform
Price Target: n/a
Current: $10.56
Upside: -
Gilead Sciences
Oct 29, 2021
Maintains: Outperform
Price Target: n/a
Current: $68.40
Upside: -
Sanofi
Sep 27, 2021
Upgrades: Outperform
Price Target: n/a
Current: $48.54
Upside: -
Theravance Biopharma
Sep 16, 2021
Maintains: Outperform
Price Target: n/a
Current: $8.32
Upside: -
FibroGen
Aug 10, 2021
Maintains: Outperform
Price Target: n/a
Current: $0.74
Upside: -
Telesis Bio
Aug 3, 2021
Maintains: Market Perform
Price Target: $342 → $684
Current: $3.74
Upside: +18,189.26%
Vertex Pharmaceuticals
Jul 30, 2021
Maintains: Underperform
Price Target: n/a
Current: $473.78
Upside: -
MorphoSys AG
Jun 3, 2021
Upgrades: Outperform
Price Target: n/a
Current: $18.10
Upside: -
Assembly Biosciences
May 10, 2021
Maintains: Market Perform
Price Target: $96 → $84
Current: $13.35
Upside: +529.21%
GSK
Mar 23, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $38.21
Upside: -
Opthea
Nov 11, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.93
Upside: -
Wave Life Sciences
Nov 28, 2018
Initiates: Outperform
Price Target: n/a
Current: $5.22
Upside: -
Biogen
Mar 16, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $228.82
Upside: -